Company Overview of Rigel Pharmaceuticals, Inc.
Gary A. Lyons
Chairman, Rigel Pharmaceuticals, Inc.
|Age||Total Calculated Compensation||This person is connected to 6 Board Members in 6 different organizations across 11 different industries.|
See Board Relationships
1180 Veterans BoulevardPhone: 650-624-1100
South San Francisco, California 94080
Board Members Memberships
The University of New Hampshire, Durham
J.L. Kellogg School of Management, Northwestern University
Annual CompensationThere is no Annual Compensation data available.
Stocks OptionsThere is no Stock Options data available.
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
|Amit D. Munshi||President, CEO & Director|
Arena Pharmaceuticals, Inc.
|Paolo Pucci||CEO & Director|
|Adam R. Craig M.D., Ph.D., M.B.A.||President, CEO & Director|
CTI BioPharma Corp.
|Mark R. Baker J.D.||Chief Executive Officer and Director|
Progenics Pharmaceuticals, Inc.
|Adelene Q. Perkins||Chairman and Chief Executive Officer|
Infinity Pharmaceuticals, Inc.
|$668.8K||Compensation as of Fiscal Year 2016.|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.